BACKGROUND: Cancer is characterized by the rampant proliferation, growth, and infiltration of malignantly transformed cancer cells past their normal boundaries into adjacent tissues. It is the leading cause of death worldwide, responsible for approximately 19.3 million new diagnoses and 10 million deaths globally in 2020. In the United States alone, the estimated number of new…
Cancer Reports Template
Write in a clean editor, then format for Cancer Reports in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Cancer Reports format
Cancer Reports is a peer-reviewed journal published by Wiley, covering Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Acute Lymphoblastic Leukemia research.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Cancer Reports 12 (3): 45–58.
Formats any DOI in Cancer Reports style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis Acute Lymphoblastic Leukemia research Head and Neck Cancer Studies Global Cancer Incidence and Screening |
| ISSN | 2573-8348 |
| Citation impact (2-yr) | 1.47 |
| h-index | 32 |
| i10-index | 261 |
| Total citations | 9,161 |
| Article processing charge | $2,300 |
| Open access | Yes |
| Top institutions publishing here | Tehran University of Medical Sciences |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Cancer Reports per year
Citation impact of Cancer Reports by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Cancer Reports
BACKGROUND: The acquisition of resistance to chemotherapy is a major hurdle in the successful application of cancer therapy. Several anticancer approaches, including chemotherapies, radiotherapy, surgery and targeted therapies are being employed for the treatment of cancer. However, cancer cells reprogram themselves in multiple ways to evade the effect of these therapies, and over a period…
BACKGROUND: -trihydroxystilbene), a natural polyphenol and phytoalexin, has drawn considerable attention in the past decade due to its wide variety of therapeutic activities such as anticancer, anti-inflammatory, and antioxidant properties. However, its poor water solubility, low chemical stability, and short biological half-life limit its clinical utility. RECENT FINDINGS: Nanoparticles overcome the limitations associated with conventional…
BACKGROUND: Brain metastases (BrM) incidence is 25% to 50% in women with advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Radiation and surgery are currently the main local treatment approaches for central nervous system (CNS) metastases. Systemic anti-HER2 therapy following a diagnosis of BrM improves outcomes. Previous preclinical data has helped elucidate HER2…
BACKGROUND: Cancer is the second most common cause of deaths worldwide. Likewise, in India, it is a major health problem, and disease burden is escalating every year. Cancer chemotherapy produces unfavorable effects on the well-being of an individual. Since the past few years, quality of life (QoL) is considered as the main goal of cancer…